A groundbreaking new blood test for Lyme disease is showing remarkable results, with over 90% accuracy across all disease stages, as presented at the 2025 Association for Diagnostics & Laboratory Medicine meeting.
Currently, diagnosing Lyme disease presents significant challenges; while some patients develop a characteristic rash, about 30% don’t show this symptom, making early detection difficult.
LymeSeek is an innovative test that simultaneously detects 10 different antigens and uses deep learning algorithms to analyze responses, delivering unprecedented sensitivity and specificity.
The results are impressive: In very early stages, LymeSeek achieved 100% accuracy compared to just 37% with standard testing. Even in posttreatment cases after 6 months, it identified 97% of cases while standard testing caught less than half.
The test is now moving toward FDA clinical trials, potentially revolutionizing how we diagnose and treat Lyme disease across all stages.
This content was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Source link : https://www.medscape.com/s/viewarticle/new-blood-test-shows-over-90-accuracy-lyme-disease-2025a1000m6s?src=rss
Author :
Publish date : 2025-08-22 17:38:00
Copyright for syndicated content belongs to the linked Source.
